NCT07480655

Brief Summary

dult patients with multiple traumatic injuries admitted to the ICU from the operating room, emergency department, or hospital wards who meet the study criteria will be included after obtaining informed consent from the patient or their legal guardian. Participants will be randomly divided into two groups: one group will receive treatment guided by the difference between carbon dioxide levels in venous and arterial blood, while the other group will receive treatment based on standard resuscitation parameters commonly used in critical care. As part of routine monitoring, all patients will have a central venous catheter and an arterial line inserted to measure blood parameters. Blood samples from both lines will be taken shortly after ICU admission and at regular intervals during the first three days. These samples will be analyzed using a bedside blood gas machine, and the results will be compared between the two groups to determine whether monitoring the difference in carbon dioxide levels between venous and arterial blood improves patient outcomes compared with standard care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2026

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

March 16, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 18, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2026

Completed
Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 15, 2026

Last Update Submit

March 15, 2026

Conditions

Keywords

Veno-arterial carbondioxide gapPolytrauma resuscitation

Outcome Measures

Primary Outcomes (1)

  • Length of mechanical ventilation

    This will be the number of days of ventilatory support once patient is admitted to ICU

Secondary Outcomes (3)

  • ICU stay

    This will the total length of ICU stay measured in number of days

  • ICU Mortality

    This will be the death occurring during ICU stay

  • qSOFA score

    This will be measured at time of admission in ICU then at 48h and 72h following admission

Study Arms (2)

Carbondioxide gap group

EXPERIMENTAL
Diagnostic Test: Veno-arterial Carbondioxide gap

Conventional resuscitation group

ACTIVE COMPARATOR
Diagnostic Test: Conventional resuscitation end points

Interventions

Arterial and central venous blood samples will be obtained for blood gas analysis using a point-of-care blood gas analyzer (ABL800 FLEX®, Radiometer). Sampling will be performed within 1 hour of ICU admission and subsequently at 6, 12, 24, 48, and 72 hours during the ICU stay. The measurements will be used to assess arterial and venous blood gas parameters for monitoring and guiding patient management.

Carbondioxide gap group

Patients in this group will be managed using standard resuscitation parameters, including monitoring of arterial base deficit, arterial pH, serum lactate levels, and bicarbonate levels. These parameters will be measured through arterial blood gas analysis within 1 hour of admission to the ICU and subsequently at 6, 12, 24, 48, and 72 hours during the ICU stay, and will be used to guide ongoing resuscitation and clinical management.

Conventional resuscitation group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Either Gender
  • Poly-trauma patients
  • ○ Both penetrating and blunt trauma
  • Both surgical and non-surgical
  • Shock States

You may not qualify if:

  • Any Chest trauma
  • Patients with Obstructive and restrictive lung disease
  • Obstructive sleep apnea
  • Septic shock
  • Pregnant patients
  • Patients who will require readmission within 48 h after step-down from the ICU.
  • Patients who will need extra-corporeal membrane oxygenation support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia, Pakistan Institute of Medical Sciences

Islamabad, Federal, 44000, Pakistan

RECRUITING

Related Publications (1)

  • Doppmann P, Meuli L, Sollid SJM, Filipovic M, Knapp J, Exadaktylos A, Albrecht R, Pietsch U. End-tidal to arterial carbon dioxide gradient is associated with increased mortality in patients with traumatic brain injury: a retrospective observational study. Sci Rep. 2021 May 17;11(1):10391. doi: 10.1038/s41598-021-89913-x.

    PMID: 34001982BACKGROUND

MeSH Terms

Conditions

Multiple Trauma

Condition Hierarchy (Ancestors)

Wounds and Injuries

Central Study Contacts

Muhammad Haroon Anwar, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 15, 2026

First Posted

March 18, 2026

Study Start

March 16, 2026

Primary Completion

June 16, 2026

Study Completion

June 16, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Hospital Ethical committee doesnt allow data sharing

Locations